About Brandon Capital Partners
Through collaboration and investment, we transform promising medical research breakthroughs into medical therapies that improve patients lives. We have supported more than 50 start-up companies to date, the majority of which were founded by us.
From early-stage seed investment through to expansion capital, we support life science companies from proof-of-concept through to commercialisation. In ANZ, we source and create our deals through Brandon BioCatalyst (formerly the Medical Research Commercialisation Fund), a unique collaboration of Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Our team are professionals with technical, business and operational experience… Continue reading about Brandon Capital Partners here.